In partnership with USAID, Project Last Mile is seeking to identify enterprises who demonstrate a proven or promising innovation to address emerging disease prevention and/or control, are poised for growth, and would benefit from Project Last Mile’s technical assistance.
To support USAID Global Health Security (GHS) objectives, this program will aim to identify and strengthen market entry and scale-up of health innovations that can strengthen prevention, detection, and/or response for infectious disease threats around the world.
Solutions should focus on late-stage development of a small form factor biomedical technology and support the following GHS Program objectives:
- Reduced spillover of emerging infectious diseases (EIDs) in humans or animals from which zoonotic pathogens spillover;
- Improved detection and/or identification of potential or real pathogens associated with EIDs; and/or
- Improved understanding of the epidemiology of EIDs among humans, animals, insects, and/or the environment.
Benefits for USAID (Biomed) program
- Each enterprise will be matched with a PLM Subject Matter Expert (SME) and will gain one-on-one technical advice, coaching, and mentoring support to design a solution to a key business challenge being faced by the enterprise.
- Enterprises may also be eligible for up to a maximum of US$200,000 in grant funding, in addition to separate technical assistance.
Eligibility Criteria
Solutions may include any new / emerging technologies, products, processes, or approaches that can support the key program objectives outlined below:
- Prevent disease outbreaks
- Detect threats early
- Respond rapidly and effectively when outbreaks occur
- Targeted sectors: Biotechnology and medical research, Health Tech in Africa.
Application Timeline
Deadline for application is on 28th July 2023
How to Apply for USAID (Biomed) Program
Click here to apply and more details.
